Chemours says top execs manipulated free cash flow, foresees no impact on results

Chemours said on Wednesday that an internal review revealed its senior executives manipulated some vendor payments and collections of receivables in the fourth quarter of 2023 in part to meet free cash flow targets, tied to their incentives.

admin